Skip to content

Heart Failure and Obesity: Effects of Weight Loss (HOW)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78790185
Enrollment
38
Registered
2006-09-29
Start date
2006-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

This is a randomised controlled study of intensive diet with weight loss against non-intervention in obese patients with heart failure. The non-intervention group is included to provide information on

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 38 patients. Pilot study: 6 patients will be recruited for active dietary intervention. Main study: 24 patients will be recruited for the active dietary intervention and 8 patients for the control. Inclusion criteria: 1. Obese patients defined at body mass index (BMI) of above 30 and <40 kg/m2 (excessive body weight will preclude exercise and accurate imaging) 2. Stable heart failure patients of NHYA (New York Heart Association) class II or III (patients must be able to undertake exercise testing). Diagnosis of heart failure will be based on standard criteria of symptoms of more than 6 months with confirmed LVEF impairment on echocardiogram 3. Age above 25 and below 70 years (to ensure patients can participate with the exercise etc)

Exclusion criteria

Exclusion criteria: 1. Unable to give informed consent 2. Subjects with renal impairment defined by creatinine >170 ?mol/l (inappropriate to include patients with more complex illness in this study). 3. Patients with Diabetes Mellitus on antidiabetic medication (other than metformin - diet and weight loss would require alteration of insulin or non-metformin diabetes treatment, complicating assessments) 4. Heart failure patients of NHYA (New York Heart Association) class III (patients must be able to undertake exercise testing)

Design outcomes

Primary

MeasureTime frame
Peak oxygen consumption during cardiopulmonary exercise testing (Peak VO2) following acute weight loss (week 6) and weight loss maintenance phase(16 weeks)

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026